Uniswap receives SEC Wells notice, founder responds by saying he'll fight it to the end
Uniswap founder Hayden Adams said on Platform X, "Uniswap Labs received a Wells Notice from the SEC today. I'm not surprised, but annoyed, disappointed, and ready to fight back. I believe that the products we offer are legitimate and our work is correct when put in historical perspective. But it's clear that instead of working on clear and sensible rules for so long, the SEC decided to focus on attacking longtime builders like Uniswap and Coinbase.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
How to Make Money With Crypto? Apeing’s 1000x Crypto Hype Hits the Final Stretch Before September 8th

Update for XRP Holders: CLARITY Act Faces a Major Timing Problem
AstraZeneca (AZN.US) breast cancer drug receives accelerated FDA approval; Wall Street expects sales to reach 2.3 billions USD by 2032.
AstraZeneca's (AZN.US) oral medication for breast cancer has been approved by the US Food and Drug Administration (FDA).
